Posts Tagged ‘Wysa’
Otsuka America launches new unit focused on digital therapeutics, AI and mental health
Otsuka defies digital health downturn with new company (MedTechDive): Otsuka America, a subsidiary of the Japanese drug and device maker, this month launched a new company focused on digital health. The firm, called Otsuka Precision Health, will roll out its first product this summer, a prescription digital therapeutic for major depressive disorder. Sanket Shah, who…
Read MoreBeyond the clinic: Can digital therapeutics (DTx) help boost mental health in the workforce at scale?
Hoping to Avoid Pear’s Fate, Behavioral Health-Focused DTx Companies Look to Employer Market (Behavioral Health Business): The digital therapeutics (DTx) industry is at a crossroads after one of the most prominent companies in the space, Pear Therapeutics, filed for bankruptcy earlier this year. The turmoil comes after DTx began catching on in the behavioral health…
Read MoreArtificial Intelligence (AI) meets Cognitive Behavioral Therapy (CBT): Wysa raises $20M to scale up mental health chatbot
Wysa raises $20 million to expand its therapist chatbot into a wider set of mental health services (TechCrunch): Wysa, a popular mental health app originally founded in India around an AI chatbot that helps users talk through their feelings, has raised $20 million in a Series B funding round to expand its business on the…
Read MoreUpdate: Playing videogames may be more cognitively beneficial than other forms of screentime like social media, watching videos/ TV
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring timely brain & mental health news and a fun brain teaser to put your temporal lobes to good use :-) #1. Study finds that playing videogames may be more cognitively beneficial for children than other forms of screentime (social media, watching videos/ TV) “Here, we estimated the impact…
Read MoreAI-enabled chatbot Wysa receives FDA Breakthrough Device designation for patients with chronic pain, depression and anxiety
AI Behavior Health Chatbot App Fast-Tracked by FDA (Psychology Today): Recently the U.S. Food and Drug Administration (FDA) granted breakthrough device designation to Wysa’s AI-based digital mental health conversational agent that delivers cognitive behavioral therapy (CBT) via a smartphone to adults suffering from depression, anxiety, and chronic musculoskeletal pain
Read MoreArtificial Intelligence (AI)-enabled chatbot Wysa raises $5.5M to broaden access to mental health support
Wysa’s AI-Guided Mental Health Platform Closes $5.5M Series A to Bridge the Gap in Employee Mental Health (press release): “Wysa, the leading global AI-powered mental health platform, today, during Mental Health Awareness Month, announced a $5.5M Series A financing round led by W Health Ventures, a Boston-based digital health investor. Others participating in the round…
Read More